PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23080159-3	2012	The transient receptor potential vanilloid 1 (TRPV1) ion channel has been implicated in thermoregulation (Caterina et al., Science 288:306-313, 2000) and recently shown to exert a tonic effect on Tb in human subjects (Gavva et al., Pain 136:202-210, 2008).	Terbium	196-198	transient receptor potential cation channel subfamily V member 1	Homo sapiens	4-44	
23080159-3	2012	The transient receptor potential vanilloid 1 (TRPV1) ion channel has been implicated in thermoregulation (Caterina et al., Science 288:306-313, 2000) and recently shown to exert a tonic effect on Tb in human subjects (Gavva et al., Pain 136:202-210, 2008).	Terbium	196-198	transient receptor potential cation channel subfamily V member 1	Homo sapiens	46-51	
23080159-4	2012	We review herein the hypothesis that TRPV1 modulates the Tb response to hypoxia.	Terbium	57-59	transient receptor potential cation channel subfamily V member 1	Homo sapiens	37-42	
31926897-1	2020	Antagonists of the transient receptor potential vanilloid-1 (TRPV1) channel alter body temperature (Tb) in laboratory animals and humans: most cause hyperthermia; some produce hypothermia; and yet others have no effect.	Terbium	100-102	transient receptor potential cation channel subfamily V member 1	Homo sapiens	19-59	
31926897-1	2020	Antagonists of the transient receptor potential vanilloid-1 (TRPV1) channel alter body temperature (Tb) in laboratory animals and humans: most cause hyperthermia; some produce hypothermia; and yet others have no effect.	Terbium	100-102	transient receptor potential cation channel subfamily V member 1	Homo sapiens	61-66	
31926897-7	2020	A Tb response occurs when a TRPV1 antagonist blocks (in case of hyperthermia) or potentiates (hypothermia) the tonic TRPV1 activation by protons somewhere in the trunk, perhaps in muscles, and - via the acido-antithermogenic and acido-antivasoconstrictor reflexes - modulates thermogenesis and skin vasoconstriction.	Terbium	2-4	transient receptor potential cation channel subfamily V member 1	Homo sapiens	28-33	
31926897-7	2020	A Tb response occurs when a TRPV1 antagonist blocks (in case of hyperthermia) or potentiates (hypothermia) the tonic TRPV1 activation by protons somewhere in the trunk, perhaps in muscles, and - via the acido-antithermogenic and acido-antivasoconstrictor reflexes - modulates thermogenesis and skin vasoconstriction.	Terbium	2-4	transient receptor potential cation channel subfamily V member 1	Homo sapiens	117-122	
31926897-8	2020	In this work, we used a mathematical model to analyze Tb data from human clinical trials of TRPV1 antagonists.	Terbium	54-56	transient receptor potential cation channel subfamily V member 1	Homo sapiens	92-97	
31926897-12	2020	We also conducted a meta-analysis of Tb data from human trials and found that polymodal TRPV1 antagonists (ABT-102, AZD1386, and V116517) increase Tb, whereas the mode-selective blocker NEO6860 does not.	Terbium	147-149	transient receptor potential cation channel subfamily V member 1	Homo sapiens	88-93